Search results

8 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Phase I clinical trial shows some promise for investigational drug for melanoma
Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.
Located in News
UNC Lineberger researchers help map genetic mutations in skin cancer
UNC Lineberger researchers significantly contributed to a better understanding of the genetic alterations found in cutaneous melanoma as part of a multi-institution, international effort of The Cancer Genome Atlas (TCGA). Researchers collected samples from 331 patients and used several molecular methodologies to complete the study, the largest of its kind to-date for cutaneous melanoma. The findings were published in the journal Cell.
Located in News
UNC Lineberger study finds new potential melanoma drug target
A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Cancer Research, the authors report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Located in News
Working wonders
UNC Lineberger member Frances Collichio, MD, was an investigator for a clinical trial for a treatment that uses a modified virus against melanoma. The treatment meant remission for Willis Davis, who had been diagnosed with stage IIIc melanoma in 2009.
Located in News
Lower survival rates connected with high-risk melanoma with mutations, study finds
A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.
Located in News
Melanoma survivors share stories of recovery amid treatment advances
UNC Lineberger and the Melanoma Research Foundation hosted “Understanding Melanoma: From Prevention to Treatment," a seminar for patients and caregivers at the William and Ida Friday Center for Continuing Education in Chapel Hill. Physicians, researchers, patients and staff spoke about advances in treatment and care for melanoma, research and prevention, as well as best practices to address the psychosocial aspects of care.
Located in News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News